Global Sickle Cell Anemia Therapeutics Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Sickle Cell Anemia Therapeutics Product Introduction
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type
  • 1.4.2 Blood Transfusion
  • 1.4.3 Pharmacotherapy
  • 1.4.4 Bone Marrow Transplant
• 1.5 Market by Application
  • 1.5.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Sickle Cell Anemia Therapeutics Market Size
  • 2.1.1 Global Sickle Cell Anemia Therapeutics Revenue 2014-2025
  • 2.1.2 Global Sickle Cell Anemia Therapeutics Sales 2014-2025
• 2.2 Sickle Cell Anemia Therapeutics Growth Rate by Regions
  • 2.2.1 Global Sickle Cell Anemia Therapeutics Sales by Regions
  • 2.2.2 Global Sickle Cell Anemia Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Sickle Cell Anemia Therapeutics Sales by Manufacturers
  • 3.1.1 Sickle Cell Anemia Therapeutics Sales by Manufacturers
  • 3.1.2 Sickle Cell Anemia Therapeutics Sales Market Share by Manufacturers
• 3.2 Sickle Cell Anemia Therapeutics Revenue by Manufacturers
  • 3.2.1 Sickle Cell Anemia Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Sickle Cell Anemia Therapeutics Revenue Share by Manufacturers (2014-2019)
• 3.3 Sickle Cell Anemia Therapeutics Price by Manufacturers
• 3.4 Sickle Cell Anemia Therapeutics Manufacturing Base Distribution, Product Types
  • 3.4.1 Sickle Cell Anemia Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Sickle Cell Anemia Therapeutics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Sickle Cell Anemia Therapeutics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Sickle Cell Anemia Therapeutics Sales by Type
• 4.2 Global Sickle Cell Anemia Therapeutics Revenue by Type
• 4.3 Sickle Cell Anemia Therapeutics Price by Type

5 Breakdown Data by Application

• 5.1 Overview
• 5.2 Global Sickle Cell Anemia Therapeutics Breakdown Data by Application

6 North America

• 6.1 North America Sickle Cell Anemia Therapeutics by Country
  • 6.1.1 North America Sickle Cell Anemia Therapeutics Sales by Country
  • 6.1.2 North America Sickle Cell Anemia Therapeutics Revenue by Country
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Sickle Cell Anemia Therapeutics by Type
• 6.3 North America Sickle Cell Anemia Therapeutics by Application

7 Europe

• 7.1 Europe Sickle Cell Anemia Therapeutics by Country
  • 7.1.1 Europe Sickle Cell Anemia Therapeutics Sales by Country
  • 7.1.2 Europe Sickle Cell Anemia Therapeutics Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Sickle Cell Anemia Therapeutics by Type
• 7.3 Europe Sickle Cell Anemia Therapeutics by Application

8 Asia Pacific

• 8.1 Asia Pacific Sickle Cell Anemia Therapeutics by Region
  • 8.1.1 Asia Pacific Sickle Cell Anemia Therapeutics Sales by Region
  • 8.1.2 Asia Pacific Sickle Cell Anemia Therapeutics Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Thailand
  • 8.1.10 Malaysia
  • 8.1.11 Philippines
  • 8.1.12 Vietnam
• 8.2 Asia Pacific Sickle Cell Anemia Therapeutics by Type
• 8.3 Asia Pacific Sickle Cell Anemia Therapeutics by Application

9 Central & South America

• 9.1 Central & South America Sickle Cell Anemia Therapeutics by Country
  • 9.1.1 Central & South America Sickle Cell Anemia Therapeutics Sales by Country
  • 9.1.2 Central & South America Sickle Cell Anemia Therapeutics Revenue by Country
  • 9.1.3 Brazil
• 9.2 Central & South America Sickle Cell Anemia Therapeutics by Type
• 9.3 Central & South America Sickle Cell Anemia Therapeutics by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Sickle Cell Anemia Therapeutics by Country
  • 10.1.1 Middle East and Africa Sickle Cell Anemia Therapeutics Sales by Country
  • 10.1.2 Middle East and Africa Sickle Cell Anemia Therapeutics Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 GCC Countries
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Sickle Cell Anemia Therapeutics by Type
• 10.3 Middle East and Africa Sickle Cell Anemia Therapeutics by Application

11 Company Profiles

• 11.1 BioMarin
  • 11.1.1 BioMarin Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 BioMarin Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 BioMarin Sickle Cell Anemia Therapeutics Products Offered
  • 11.1.5 BioMarin Recent Development
• 11.2 Bluebird Bio
  • 11.2.1 Bluebird Bio Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bluebird Bio Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bluebird Bio Sickle Cell Anemia Therapeutics Products Offered
  • 11.2.5 Bluebird Bio Recent Development
• 11.3 DeuteRx
  • 11.3.1 DeuteRx Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 DeuteRx Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 DeuteRx Sickle Cell Anemia Therapeutics Products Offered
  • 11.3.5 DeuteRx Recent Development
• 11.4 Emmaus Medical
  • 11.4.1 Emmaus Medical Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Emmaus Medical Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Emmaus Medical Sickle Cell Anemia Therapeutics Products Offered
  • 11.4.5 Emmaus Medical Recent Development
• 11.5 Gamida Cell
  • 11.5.1 Gamida Cell Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Gamida Cell Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Gamida Cell Sickle Cell Anemia Therapeutics Products Offered
  • 11.5.5 Gamida Cell Recent Development
• 11.6 Global Blood Therapeutics
  • 11.6.1 Global Blood Therapeutics Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Products Offered
  • 11.6.5 Global Blood Therapeutics Recent Development
• 11.7 GlycoMimetics
  • 11.7.1 GlycoMimetics Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 GlycoMimetics Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 GlycoMimetics Sickle Cell Anemia Therapeutics Products Offered
  • 11.7.5 GlycoMimetics Recent Development
• 11.8 Modus Therapeutics
  • 11.8.1 Modus Therapeutics Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Modus Therapeutics Sickle Cell Anemia Therapeutics Products Offered
  • 11.8.5 Modus Therapeutics Recent Development
• 11.9 Pfizer
  • 11.9.1 Pfizer Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Pfizer Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Pfizer Sickle Cell Anemia Therapeutics Products Offered
  • 11.9.5 Pfizer Recent Development
• 11.10 Sancilio Pharmaceuticals
  • 11.10.1 Sancilio Pharmaceuticals Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Products Offered
  • 11.10.5 Sancilio Pharmaceuticals Recent Development
• 11.11 Sangamo Biosciences

12 Future Forecast

• 12.1 Sickle Cell Anemia Therapeutics Market Forecast by Regions
  • 12.1.1 Global Sickle Cell Anemia Therapeutics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Sickle Cell Anemia Therapeutics Revenue Forecast by Regions 2019-2025
• 12.2 Sickle Cell Anemia Therapeutics Market Forecast by Type
  • 12.2.1 Global Sickle Cell Anemia Therapeutics Sales Forecast by Type 2019-2025
  • 12.2.2 Global Sickle Cell Anemia Therapeutics Revenue Forecast by Type 2019-2025
• 12.3 Sickle Cell Anemia Therapeutics Market Forecast by Application
• 12.4 North America Sickle Cell Anemia Therapeutics Forecast
• 12.5 Europe Sickle Cell Anemia Therapeutics Forecast
• 12.6 Asia Pacific Sickle Cell Anemia Therapeutics Forecast
• 12.7 Central & South America Sickle Cell Anemia Therapeutics Forecast
• 12.8 Middle East and Africa Sickle Cell Anemia Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Sickle Cell Anemia Therapeutics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details